Published in Mayo Clin Proc on February 01, 1994
Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther (2010) 1.40
Acellular nerve allografts in peripheral nerve regeneration: a comparative study. Muscle Nerve (2011) 1.18
Overcoming short gaps in peripheral nerve repair: conduits and human acellular nerve allograft. Hand (N Y) (2014) 0.96
Tacrolimus (FK506)-Associated Renal Pathology. Adv Anat Pathol (1997) 0.90
Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. Clin Transplant (1997) 0.90
Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysis. Hepatology (2010) 0.86
Risk factors for acute kidney injury following orthotopic liver transplantation: the impact of changes in renal function while patients await transplantation. BMC Nephrol (2010) 0.84
Acute renal failure in liver transplant patients: Indian study. Indian J Clin Biochem (2013) 0.77
Nephrotoxic effects of immunosuppression. Mayo Clin Proc (1994) 0.75
Maintenance pharmacological immunosuppressive strategies in renal transplantation. Postgrad Med J (1997) 0.75
Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients. BMC Gastroenterol (2017) 0.75
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene (2007) 7.02
Biliary tract cancers. N Engl J Med (1999) 6.36
MELD and PELD: application of survival models to liver allocation. Liver Transpl (2001) 3.76
Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest (2000) 3.58
Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology (1980) 3.57
Renal-artery stenosis. N Engl J Med (2001) 3.38
Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg (1999) 2.79
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA (1999) 2.78
Postural tachycardia syndrome (POTS). Neurology (1995) 2.59
Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology (1999) 2.56
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology (1989) 2.39
Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res (2000) 2.38
Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med (1997) 2.38
Current concepts. Primary sclerosing cholangitis. N Engl J Med (1984) 2.35
The role of proteases during apoptosis. FASEB J (1996) 2.35
Apoptosis: a mechanism of acute and chronic liver injury. Gut (2005) 2.33
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest (1999) 2.32
Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl (2000) 2.27
The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol (2000) 2.25
Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology (1996) 2.23
Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl (2000) 2.23
Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology (1999) 2.20
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology (1994) 2.10
Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1991) 2.06
Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest (1990) 1.99
Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med (1987) 1.98
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc (1989) 1.93
Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol (2001) 1.93
Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology (1982) 1.88
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection. Am J Transplant (2008) 1.86
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant (2006) 1.83
Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78
Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology (1990) 1.76
A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis (1995) 1.71
Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc (1988) 1.71
Detection of cytomegalovirus DNA in sera of liver transplant recipients. J Clin Microbiol (1994) 1.69
Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology (1990) 1.69
The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg (1997) 1.68
Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest (1997) 1.67
Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc (1995) 1.64
Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis. Ann Surg (1993) 1.63
Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology (1996) 1.62
Choledochocholedochostomy, a relatively safe procedure in orthotopic liver transplantation. Surgery (1985) 1.61
Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc (1993) 1.59
Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc (1995) 1.59
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant (2014) 1.57
Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc (1990) 1.56
Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation (1999) 1.56
Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology (1997) 1.54
Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology (1993) 1.53
Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol (2001) 1.52
Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc (2000) 1.51
Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology (1992) 1.51
Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol (2000) 1.51
Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology (1983) 1.49
Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology (1999) 1.49
Drug-induced liver injury: mechanisms and test systems. Hepatology (2001) 1.49
Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes. Am J Physiol (1993) 1.49
Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study. Liver Transpl (2001) 1.48
Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol (1997) 1.47
Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism. J Biol Chem (1992) 1.47
Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology (1995) 1.47
Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology (1998) 1.46
Cholestasis confers resistance to the rat liver mitochondrial permeability transition. Gastroenterology (1998) 1.46
Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J Clin Invest (1993) 1.46
Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology (1992) 1.46
A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc (2000) 1.45
Death receptors in liver biology and pathobiology. Hepatology (1999) 1.45
Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clin Proc (2001) 1.45
Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation (1996) 1.44
Retracted Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy. Gastroenterology (1992) 1.43
Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis. Gastroenterology (1986) 1.43
The autologous mixed lymphocyte reaction in primary biliary cirrhosis: analysis of activation and blastogenesis of autoreactive T lymphocytes. Hepatology (1988) 1.43
Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc (1994) 1.43
Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest (1994) 1.42
Nutritional support for liver transplantation: identifying caloric and protein requirements. Mayo Clin Proc (1994) 1.42
Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant (2006) 1.42
The role of portosystemic shunts for variceal bleeding in the liver transplantation era. Arch Surg (1994) 1.40